Addressing Emerging Infectious Diseases in Veterinary Medicine: Global Health Challenges and Solutions
Abstract
Emerging infectious diseases (EIDs) pose significant threats to global health, encompassing both human and animal populations. In veterinary medicine, these challenges manifest in various forms, ranging from zoonotic diseases to novel pathogens impacting livestock and wildlife. This abstract explores the multifaceted nature of addressing EIDs within the realm of veterinary medicine, highlighting global health challenges and proposing potential solutions. One of the primary challenges in combating EIDs in veterinary medicine is the interconnectedness of human and animal health. Zoonotic diseases, such as avian influenza and Ebola, underscore the importance of One Health approaches that recognize the intimate linkages between animals, humans, and the environment. Additionally, the globalization of trade and travel facilitates the rapid spread of infectious agents across borders, necessitating coordinated international responses. Veterinary medicine faces unique hurdles in EID surveillance, diagnosis, and control. Limited resources, particularly in low- and middle-income countries, often impede effective disease monitoring and response efforts. Furthermore, the emergence of antimicrobial resistance poses a formidable threat to both animal and human health, necessitating judicious antimicrobial use and innovative strategies for disease management. To address these challenges, collaborative frameworks involving veterinarians, public health professionals, policymakers, and researchers are essential. Enhanced surveillance networks, investment in diagnostic capacity, and research into emerging pathogens are paramount.
References
[2] Gaudreault, N.N.; Madden, D.W.; Wilson, W.C.; Trujillo, J.D.; Richt, J.A. African Swine Fever Virus: An Emerging DNA Arbovirus. Front. Vet. Sci. 2020, 7, 215.
[3] Park, M.J.; Cha, R.M.; Kye, S.J.; Lee, Y.N.; Kim, N.Y.; Baek, Y.G.; Heo, G.B.; Sagong, M.; Lee, K.N.; Lee, Y.J.; et al. Pathogenicity of H5N8 High Pathogenicity Avian Influenza Virus in Chickens and Ducks from South Korea in 2020–2021. Viruses 2021, 13, 1903.
[4] Lee, D.H.; Criado, M.F.; Swayne, D.E. Pathobiological Origins and Evolutionary History of Highly Pathogenic Avian Influenza Viruses. Cold Spring Harb. Perspect. Med. 2021, 11, a038679.
[5] Dumkow, L.E.; Worden, L.J.; Rao, S.N. Syndromic diagnostic testing: A new way to approach patient care in the treatment of infectious diseases. J. Antimicrob. Chemother. 2021, 76, iii4–iii11.
[6] Dien Bard, J.; McElvania, E. Panels and Syndromic Testing in Clinical Microbiology. Clin. Lab. Med. 2020, 40, 393–420.
[7] Srivastava, P.; Prasad, D. Isothermal nucleic acid amplification and its uses in modern diagnostic technologies. 3 Biotech 2023, 13, 200.
[8] Obande, G.A.; Banga Singh, K.K. Current and Future Perspectives on Isothermal Nucleic Acid Amplification Technologies for Diagnosing Infections. Infect. Drug Resist. 2020, 13, 455–483.
[9] Islam, M.M.; Koirala, D. Toward a next-generation diagnostic tool: A review on emerging isothermal nucleic acid amplification techniques for the detection of SARS-CoV-2 and other infectious viruses. Anal. Chim. Acta 2022, 1209, 339338.
[10] Nyaruaba, R.; Mwaliko, C.; Dobnik, D.; Neuzil, P.; Amoth, P.; Mwau, M.; Yu, J.; Yang, H.; Wei, H. Digital PCR Applications in the SARS-CoV-2/COVID-19 Era: A Roadmap for Future Outbreaks. Clin. Microbiol. Rev. 2022, 35, e0016821.
[11] Merino, I.; de la Fuente, A.; Dominguez-Gil, M.; Eiros, J.M.; Tedim, A.P.; Bermejo-Martin, J.F. Digital PCR applications for the diagnosis and management of infection in critical care medicine. Crit. Care 2022, 26, 63.
[12] Chen, B.; Jiang, Y.; Cao, X.; Liu, C.; Zhang, N.; Shi, D. Droplet digital PCR as an emerging tool in detecting pathogens nucleic acids in infectious diseases. Clin. Chim. Acta 2021, 517, 156–161.
[13] Samuel, L. Point-of-Care Testing in Microbiology. Clin. Lab. Med. 2020, 40, 483–494.
[14] Zhang, J.Y.; Bender, A.T.; Boyle, D.S.; Drain, P.K.; Posner, J.D. Current state of commercial point-of-care nucleic acid tests for infectious diseases. Analyst 2021, 146, 2449–2462.
[15] Gerlier, C.; Pilmis, B.; Ganansia, O.; Le Monnier, A.; Nguyen Van, J.C. Clinical and operational impact of rapid point-of-care SARS-CoV-2 detection in an emergency department. Am. J. Emerg. Med. 2021, 50, 713–718.
[16] Pritzker, K. Impact of the COVID-19 pandemic on Molecular Diagnostics. Expert Rev. Mol. Diagn. 2021, 21, 519–521.
